IL138060A - Diagnostic methods for detecting cancer - Google Patents

Diagnostic methods for detecting cancer

Info

Publication number
IL138060A
IL138060A IL13806099A IL13806099A IL138060A IL 138060 A IL138060 A IL 138060A IL 13806099 A IL13806099 A IL 13806099A IL 13806099 A IL13806099 A IL 13806099A IL 138060 A IL138060 A IL 138060A
Authority
IL
Israel
Prior art keywords
diagnostic methods
detecting cancer
crd
level
cancer
Prior art date
Application number
IL13806099A
Other languages
English (en)
Other versions
IL138060A0 (en
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of IL138060A0 publication Critical patent/IL138060A0/xx
Publication of IL138060A publication Critical patent/IL138060A/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57525—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the liver or pancreas
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57535—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the large intestine, e.g. colon, rectum or anus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL13806099A 1998-03-09 1999-03-05 Diagnostic methods for detecting cancer IL138060A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7737298P 1998-03-09 1998-03-09
PCT/US1999/004897 WO1999046594A2 (en) 1998-03-09 1999-03-05 C-myc coding region determinant-binding protein (crd-bp)

Publications (2)

Publication Number Publication Date
IL138060A0 IL138060A0 (en) 2001-10-31
IL138060A true IL138060A (en) 2005-03-20

Family

ID=22137674

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13806099A IL138060A (en) 1998-03-09 1999-03-05 Diagnostic methods for detecting cancer

Country Status (10)

Country Link
US (2) US6255055B1 (de)
EP (1) EP1062514B1 (de)
JP (1) JP3535095B2 (de)
AT (1) ATE278962T1 (de)
AU (1) AU733428B2 (de)
CA (1) CA2321610C (de)
DE (1) DE69920885T2 (de)
IL (1) IL138060A (de)
NZ (1) NZ506480A (de)
WO (1) WO1999046594A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6696247B2 (en) 1998-03-18 2004-02-24 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6960570B2 (en) 1998-03-18 2005-11-01 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US7579160B2 (en) * 1998-03-18 2009-08-25 Corixa Corporation Methods for the detection of cervical cancer
US7258860B2 (en) 1998-03-18 2007-08-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6297364B1 (en) * 1998-04-17 2001-10-02 Ludwig Institute For Cancer Research Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
US7314926B1 (en) * 1999-04-08 2008-01-01 Antisoma Research Limited Antiproliferative activity of g-rich oligonucleotides and method of using same to bind to nucleolin
US8114850B2 (en) * 1999-04-08 2012-02-14 Advanced Cancer Therapeutics, Llc Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
US20080318889A1 (en) * 1999-04-08 2008-12-25 Antisoma Research Limited Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
US20080318890A1 (en) * 1999-04-08 2008-12-25 Antisoma Research Limited Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
US7960540B2 (en) * 1999-04-08 2011-06-14 Advanced Cancer Therapeutics, Llc Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin
WO2002020036A1 (de) * 2000-09-06 2002-03-14 Mueller Friederike Arzneimittel mit einer für das rna-bindende koc-protein kodierenden dna-sequenz, einem koc-protein oder einer dna-sequenz des koc-promotors
DE102004026135A1 (de) * 2004-05-25 2006-01-05 Immatics Biotechnologies Gmbh An MHC-Moleküle bindende Tumor-assoziierte Peptide
US7632828B2 (en) * 2004-06-10 2009-12-15 Fob Synthesis, Inc. Gram-positive carbapenem antibacterials and processes for their preparation
WO2006038212A2 (en) * 2004-10-04 2006-04-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem Methods and compositions for the diagnosis and treatment of cancer
PL2325306T3 (pl) 2005-02-25 2014-07-31 Oncotherapy Science Inc Szczepionki peptydowe do zastosowania w nowotworach płuc, wykazujących ekspresję polipeptydów TTK, URLC10 lub KOC1
WO2008020652A1 (en) * 2006-08-18 2008-02-21 Oncotherapy Science, Inc. Imp-1 oncogene as a therapeutic target and prognostic indicator for lung cancer
US20090131351A1 (en) * 2007-11-16 2009-05-21 Antisoma Research Limited Methods, compositions, and kits for modulating tumor cell proliferation
RS53872B2 (sr) 2008-05-14 2018-06-29 Immatics Biotechnologies Gmbh Novi i snažni mhc peptidi klase ii izvedeni iz survivina i neurokana
EP4353321A3 (de) * 2014-08-04 2024-07-10 OncoTherapy Science, Inc. Koc1-abgeleitetes peptid und impfstoff damit
GB201505305D0 (en) 2015-03-27 2015-05-13 Immatics Biotechnologies Gmbh Novel Peptides and combination of peptides for use in immunotherapy against various tumors
FI3273986T3 (fi) 2015-03-27 2024-02-07 Immatics Biotechnologies Gmbh Uusia peptidejä ja peptidien yhdistelmiä käytettäväksi immunoterapiassa eri syöpiä vastaan

Also Published As

Publication number Publication date
WO1999046594A2 (en) 1999-09-16
US6255055B1 (en) 2001-07-03
AU3069799A (en) 1999-09-27
US20020061543A1 (en) 2002-05-23
US6794151B2 (en) 2004-09-21
NZ506480A (en) 2003-06-30
ATE278962T1 (de) 2004-10-15
JP2002506971A (ja) 2002-03-05
EP1062514A2 (de) 2000-12-27
AU733428B2 (en) 2001-05-17
IL138060A0 (en) 2001-10-31
DE69920885D1 (en) 2004-11-11
DE69920885T2 (de) 2006-02-02
WO1999046594A3 (en) 1999-12-09
EP1062514B1 (de) 2004-10-06
CA2321610C (en) 2005-12-20
JP3535095B2 (ja) 2004-06-07
CA2321610A1 (en) 1999-09-16

Similar Documents

Publication Publication Date Title
IL138060A0 (en) C-myc coding region determinant-binding protein (crd-bp)
AU2003260966A1 (en) Genes and polypeptides relating to human pancreatic cancers
EP2228654A3 (de) Diagnose und Behandlung der Invasion von Krebszellen
AU6232099A (en) Method and apparatus for determining autofluorescence of skin tissue
WO2000018954A3 (en) Use of pex in the treatment of metabolic bone diseases
WO2004034875A3 (en) Medical device sheath apparatus and method
NZ330887A (en) Monoclonals and polyclonals antibodies for the diagnosis of breast cancer
NO976063L (no) Fremgangsmåte for behandling av diabetes
AU3550099A (en) Methods and devices for the localization of lesions in solid tissue
WO2007076435A3 (en) Defibrillator with implantable medical device detection
WO2005010486A3 (en) Biomarker panel for colorectal cancer
WO1999051142A3 (en) Non-invasive tissue glucose level monitoring
EP1593407A3 (de) Strahlungsschutzvorrichtung
WO2004031414A3 (en) Method for diagnosing prostate cancer
GR3031250T3 (en) Methods of diagnosing and treating preeclampsia
DE69231734D1 (de) Geerbte und somatische mutationen des apc-gens bei menschlichem colorectal-krebs
Riker et al. Cutaneous melanoma: methods of biopsy and definitive surgical excision
IL142340A0 (en) Methods for identification, diagnosis, and treatment of breast cancer
WO2001065998A3 (en) Methods for the diagnosis and treatment of breast cancer
WO2004038045A3 (en) Method for diagnosing diffuse-type gastric cancer
WO2005034926A3 (en) Non-invasive system for detecting skin cancer
GR3006236T3 (de)
AU2003266228A1 (en) Diagnostic agent, method for detecting a carcinoma, and means for the treatment thereof
WO2000071081A3 (en) Methods of diagnosis and treatment of meniere disease
WO2000073338A8 (en) Compositions and methods for the therapy, diagnosis and monitoring of breast cancer

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees